— Know what they know.
Not Investment Advice

086450.KQ KOE

DongKook Pharmaceutical Co., Ltd.
1W: +6.6% 1M: +3.9% 3M: +12.9% YTD: +23.0% 1Y: +22.5% 3Y: +70.2% 5Y: -15.9%
₩22,750.00 ($16.96)
+600.00 (+2.71%)
 
Weekly Expected Move ±5.4%
₩20300 ₩21525 ₩22750 ₩23975 ₩25200
KOE · Healthcare · Medical - Pharmaceuticals · Tech Score Buy · Power 61 · ₩1.03T mcap · 25M float · 1.81% daily turnover

📊 Key Metrics

TTM
₩980B
Revenue
+12.7% YoY
₩76B
Net Income
+26.9% YoY
₩36B
Free Cash Flow
-21.9% YoY
54.5%
Gross Margin
10.1%
Op. Margin
6.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE11.5%
ROA7.2%
ROIC12.9%

Valuation

P/E13.4
P/B1.5
EV/EBITDA6.0

Leverage

Debt/Equity0.10
Current Ratio2.05
Interest Cov.5.6x

Quality Scores

Piotroski F7/9
Altman Z3.90
Beneish M-2.41

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms